Literature DB >> 9532416

Assessing microcirculation in familial dysautonomia by laser Doppler flowmeter.

M Weiser1, M J Hilz, L Bronfin, F B Axelrod.   

Abstract

Microcirculatory vasomotor responses to an alpha-adrenergic agonist and an antagonist were assessed in 11 familial dysautonomia and nine control subjects by laser Doppler flowmetry. Using two iontophoresis machines, blood flow in the midclavicular areas was continuously monitored by two channel laser Doppler flowmeter. Simultaneously, the alpha-antagonist (0.5 mM phentolamine hydrochloride) and a control solution (0.9% saline) were iontophoresed at 200 microA for 15 min. The alpha-agonist (0.5 mM norepinephrine bitartrate) was then iontophoresed (20 microA) to both pretreated areas for progressively longer pulses separated by 3-min observation intervals (15, 30, 60, 90, 120 s). The familial dysautonomia subject group had higher mean baseline perfusion with widely fluctuating baselines, especially on the phentolamine pretreated side (P = 0.03). Saline iontophoresis significantly increased perfusion in the control group, but not in the familial dysautonomia group (ANOVA: P = 0.02 and 0.15, respectively). There was > 100% increase in flow by the end of the saline observation period in seven of nine controls, but in only three of 11 familial dysautonomia subjects. Phentolamine iontophoresis differentiated familial dysautonomia subjects into responders and nonresponders by 7-8 min when all nine control subjects, but only five of 11 familial dysautonomia subjects, had > 200% increase in blood flow. Irrespective of pretreatment type, norepinephrine decreased blood flow in both familial dysautonomia and control groups (ANOVA: P < 0.0001), but the final mean change after saline was greater in the control group, P = 0.02. The final mean changes of flow after phentolamine pretreatment were not different between the two groups and were comparable to the familial dysautonomia group's smaller response after saline pretreatment. Higher baseline perfusion suggests dilation may be intrinsic to familial dysautonomia vasculature. Two populations of familial dysautonomia subjects are noted; those who like controls increase blood flow with iontophoresis of the alpha-antagonist and those who are refractory. In addition, in familial dysautonomia subjects, the microcirculatory constrictive response to alpha-agonist iontophoresis is less than that observed for controls. These data suggest that some familial dysautonomia subjects may have decreased or dysfunctional adrenoceptors as well as decreased innervation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9532416     DOI: 10.1007/bf02267599

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  13 in total

1.  EXAGGERATED RESPONSE TO INFUSED NOREPINEPHRINE IN FAMILIAL DYSAUTONOMIA.

Authors:  A A SMITH; J DANCIS
Journal:  N Engl J Med       Date:  1964-04-02       Impact factor: 91.245

2.  RESPONSES TO INFUSED METHACHOLINE IN FAMILIAL DYSAUTONOMIA.

Authors:  A A SMITH; J I HIRSCH; J DANCIS
Journal:  Pediatrics       Date:  1965-08       Impact factor: 7.124

3.  Adrenergic receptors in the forehead microcirculation.

Authors:  P D Drummond
Journal:  Clin Auton Res       Date:  1996-02       Impact factor: 4.435

4.  Laser Doppler flow-meter assessment of iontophoretically applied norepinephrine on human finger skin circulation.

Authors:  L E Lindblad; L Ekenvall; K Ancker; H Rohman; P A Oberg
Journal:  J Invest Dermatol       Date:  1986-11       Impact factor: 8.551

5.  Trophic functions of the neuron. V. Familial dysautonomis. Current concepts of dysautonomia: neuropathological defects.

Authors:  J Pearson; F Axelrod; J Dancis
Journal:  Ann N Y Acad Sci       Date:  1974-03-22       Impact factor: 5.691

6.  Quantitative studies of sympathetic ganglia and spinal cord intermedio-lateral gray columns in familial dysautonomia.

Authors:  J Pearson; B A Pytel
Journal:  J Neurol Sci       Date:  1978-11       Impact factor: 3.181

7.  Deficient sympathetic nervous response in familial dysautonomia.

Authors:  M G Ziegler; C R Lake; I J Kopin
Journal:  N Engl J Med       Date:  1976-03-18       Impact factor: 91.245

8.  Patterns of plasma levels of catechols in neurogenic orthostatic hypotension.

Authors:  D S Goldstein; R J Polinsky; M Garty; D Robertson; R T Brown; I Biaggioni; R Stull; I J Kopin
Journal:  Ann Neurol       Date:  1989-10       Impact factor: 10.422

9.  Quantitative studies of dorsal root ganglia and neuropathologic observations on spinal cords in familial dysautonomia.

Authors:  J Pearson; B A Pytel; N Grover-Johnson; F Axelrod; J Dancis
Journal:  J Neurol Sci       Date:  1978-01       Impact factor: 3.181

10.  Atrial natriuretic peptide response to postural change and medication in familial dysautonomia.

Authors:  F B Axelrod; L Krey; J S Glickstein; D Friedman; J Weider; L J Metakis; V M Porges; M Mineo; D Notterman
Journal:  Clin Auton Res       Date:  1994-12       Impact factor: 4.435

View more
  4 in total

1.  Dermal microdialysis provides evidence for hypersensitivity to noradrenaline in patients with familial dysautonomia.

Authors:  A Bickel; F B Axelrod; M Schmelz; H Marthol; M J Hilz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-09       Impact factor: 10.154

Review 2.  Assessment of cutaneous axon-reflex responses to evaluate functional integrity of autonomic small nerve fibers.

Authors:  Mido M Hijazi; Sylvia J Buchmann; Annahita Sedghi; Ben M Illigens; Heinz Reichmann; Gabriele Schackert; Timo Siepmann
Journal:  Neurol Sci       Date:  2020-03-03       Impact factor: 3.307

Review 3.  Imaging of the Intestinal Microcirculation during Acute and Chronic Inflammation.

Authors:  Kayle Dickson; Hajer Malitan; Christian Lehmann
Journal:  Biology (Basel)       Date:  2020-11-26

Review 4.  Laser Doppler Assessment of Vasomotor Axon Reflex Responsiveness to Evaluate Neurovascular Function.

Authors:  Marie Luise Kubasch; Anne Sophie Kubasch; Juliana Torres Pacheco; Sylvia J Buchmann; Ben Min-Woo Illigens; Kristian Barlinn; Timo Siepmann
Journal:  Front Neurol       Date:  2017-08-14       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.